Catalyst Wire Dossier Catalyst Wire Dossier

CHS-114 (Tagmokitug)

Tagmokitug · Coherus Oncology, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHS-114 (Tagmokitug), covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors [Phase 1]

See pricing